PFx Biotech utilizes precision fermentation to produce bioactive human milk proteins as alternative proteins, specifically targeting the dietary needs of individuals with cow milk protein allergies. Their products cater to various nutritional applications, including sports performance, medical nutrition, and early-life development, while promoting sustainability in food production.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cow milk protein allergy is a common issue, especially in infants, requiring specialized dietary solutions. Current alternative protein sources may lack the bioactivity and nutritional profile of human milk proteins. Traditional protein production methods can be environmentally unsustainable.
Solution
PFx Biotech uses precision fermentation to produce bioactive human milk proteins as alternative protein ingredients. Their platform leverages a systems biology approach to create highly bioactive human milk protein ingredients via a scalable precision fermentation process. These alternative proteins are designed for advanced nutrition applications, addressing needs in sports performance, medical nutrition, elderly care, and early-life development. This approach offers a sustainable method for producing proteins with tailored nutritional profiles.
Target Audience
The primary target audience includes individuals with cow milk protein allergies, athletes, individuals with specific medical nutrition needs, the elderly, and infants requiring specialized nutrition.
Features
- Production of human milk proteins via precision fermentation
- Novel systems biology approach for enhanced bioactivity
- Scalable production process
- Alternative proteins for sports performance
- Alternative proteins for medical nutrition
- Alternative proteins for elderly care
- Alternative proteins for early-life development